Ann: Race Appoints George Clinical for Phase 1 Trial of RC220, page-120

I get this better than you think! This is an old study, in fact it's pushing 4 decades old and almost completely irrelevant to current paradigm, other than perhaps for the safety part. So we can debate all the dosing caveats, ethics etc but it's all moot. However, the conclusions whether we like them or not now were probably appropriate for the time. But you can't on the one hand trash the study, while simultaneously taking what you think is the "good bit" from it about bis survival being "greater" (which even the company on this forum agrees isn't strictly accurate) and use that in current promotional decks.
Not being difficult, I actually like the look of this as I research more, and particularly like that the company makes the effort to interact on this forum, it raises the level of discourse for sure, unlike other company forums!